Translational Psychiatry,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: Sept. 8, 2022
Abstract
Opioid
exposure
is
known
to
cause
transcriptomic
changes
in
the
nucleus
accumbens
(NAc).
However,
no
studies
date
have
investigated
cell
type-specific
associated
with
volitional
opioid
taking.
Here,
we
use
single
RNA
sequencing
(snRNAseq)
comprehensively
characterize
alterations
of
NAc
transcriptome
rats
self-administering
morphine.
One
cohort
male
Brown
Norway
was
injected
acute
morphine
(10
mg/kg,
i.p.)
or
saline.
A
second
allowed
self-administer
intravenous
(1.0
mg/kg/infusion)
for
10
consecutive
days.
Each
morphine-experienced
rat
paired
a
yoked
saline
control
rat.
snRNAseq
libraries
were
generated
from
punches
and
used
identify
gene
expression
We
identified
1106
differentially
expressed
genes
(DEGs)
group,
compared
2453
DEGs
self-administration
across
27
distinct
clusters.
Importantly,
1329
that
specific
self-administration.
novel
clusters
astrocytes,
oligodendrocytes,
D1R-
D2R-expressing
medium
spiny
neurons
NAc.
Cell
included
Rgs9
,
Celf5
Oprm1
Pde10a
.
Upregulation
validated
by
RNAscope.
Approximately
85%
all
oligodendrocyte
DEGs,
nearly
which
taking,
two
subtypes.
Bioinformatic
analyses
upstream
regulatory
mechanisms
observed
downstream
signaling
pathways,
including
both
previously
molecular
pathways.
These
findings
show
taking
highlight
striatal
populations
substrates
could
be
targeted
reduce
compulsive
The Annual Review of Pharmacology and Toxicology,
Journal Year:
2015,
Volume and Issue:
56(1), P. 299 - 322
Published: Oct. 30, 2015
The
identification
of
a
heuristic
framework
for
the
stages
addiction
cycle
that
are
linked
to
neurocircuitry
changes
in
pathophysiology
includes
binge/intoxication
stage,
withdrawal/negative
affect
and
preoccupation/anticipation
(craving)
which
represent
neuroadaptations
three
neurocircuits
(basal
ganglia,
extended
amygdala,
frontal
cortex,
respectively).
excellent
validated
animal
models,
development
human
laboratory
an
enormous
surge
our
understanding
neuropharmacological
mechanisms
have
provided
revisionist
view
emphasizes
loss
brain
reward
function
gain
stress
drive
negative
reinforcement
(the
dark
side
addiction)
as
key
compulsive
drug
seeking.
Reversing
not
only
explains
much
existing
successful
pharmacotherapies
but
also
points
vast
new
opportunities
future
medications
alleviate
this
major
source
suffering.
ACS Chemical Neuroscience,
Journal Year:
2017,
Volume and Issue:
8(5), P. 1065 - 1073
Published: Jan. 21, 2017
Opioid
use
disorder
(OUD)
is
a
major
public
health
problem.
High
relapse
rates
and
poor
treatment
retention
continue
to
pose
challenges
in
OUD
treatment.
Of
the
abused
opioids,
oxycodone
well
described
maintain
self-administration
evoke
durable
conditioned
responses
("cue
reactivity")
that
result
from
pairing
of
opioid-related
stimuli
(e.g.,
paraphernalia)
with
repeated
abuse.
Serotonin
(5-HT)
neurotransmission,
particularly
through
5-HT2C
receptor
(5-HT2CR),
regulates
psychostimulant
reward
cue
reactivity,
present
experiments,
we
investigated
hypothesis
selective
5-HT2CR
agonist
lorcaserin,
which
approved
by
United
States
Food
Drug
Administration
(FDA)
for
obesity,
will
suppress
oxycodone-associated
reactivity
rats.
We
found
lorcaserin
inhibited
intake,
an
effect
blocked
antagonist
SB242084.
Lorcaserin
also
decreased
responding
discrete
complex
previously
associated
delivery
(i.e.,
stimulus
lights,
infusion
pump
sounds)
both
abstinence
extinction-reinstatement
models.
The
selected
dose
range
(0.25-1
mg/kg)
does
not
overtly
alter
spontaneous
behaviors
nor
operant
on
inactive
levers
study.
Taken
together,
ability
reduce
decrease
highlights
therapeutic
potential
OUD.
Journal of Pharmacology and Experimental Therapeutics,
Journal Year:
2023,
Volume and Issue:
385(2), P. 117 - 134
Published: Feb. 24, 2023
The
opioid
overdose
death
toll
in
the
United
States
is
an
ongoing
public
health
crisis.
We
characterized
magnitude
and
duration
of
respiratory
depression,
leading
cause
cases,
induced
by
heroin
or
fentanyl
development
tolerance
male
female
rats.
used
whole-body
plethysmography
to
first
establish
dose-response
curves
recording
breathing
for
60
minutes
post-intravenous
injection.
then
tested
acute
over
several
weeks
chronic
with
challenge.
Heroin
each
provoked
dose-dependent
depression.
caused
prolonged
(45–60
minute)
depression
rats,
decreased
frequency,
tidal
volume,
minute
ventilation
increased
inspiratory
time
apneic
pause.
Fentanyl
produced
similar
changes
a
shorter
(10–15
minutes).
High-dose
robust
that
was
slightly
more
severe
females
and,
when
given
intermittently
(acute
doses
2
3
apart),
did
not
lead
tolerance.
In
contrast,
delivered
osmotic
minipump
resulted
heroin,
This
effect
persisted
during
withdrawal
males
only.
Our
model
experimental
design
will
allow
investigation
neurobiology
opioid-induced
testing
potential
therapeutics
reverse
stimulate
breathing.
SIGNIFICANCE
STATEMENT
potent
had
producing
than
both
sexes,
whereas
rats
were
sensitive
heroin-induced
Tolerance/cross-tolerance
develops
administration
but
minimized
long
interadministration
intervals.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 14, 2025
Abstract
Large
library
docking
of
tangible
molecules
has
revealed
potent
ligands
across
many
targets.
While
make-on-demand
libraries
now
exceed
75
billion
enumerated
molecules,
their
synthetic
routes
are
dominated
by
a
few
reaction
types,
reducing
diversity
and
inevitably
leaving
interesting
bioactive-like
chemotypes
unexplored.
Here,
we
investigate
the
large-scale
enumeration
targeted
isoquinuclidines.
These
“natural-product-like”
rare
in
current
functionally
congested,
making
them
as
receptor
probes.
Using
modular,
four-component
scheme,
built
docked
virtual
over
14.6
million
isoquinuclidines
against
both
µ-
κ
-opioid
receptors
(MOR
KOR,
respectively).
Synthesis
experimental
testing
18
prioritized
compounds
found
nine
with
low
µM
affinities.
Structure-based
optimization
low-
sub-
nM
antagonists
inverse
agonists
targeting
receptors.
Cryo-electron
microscopy
(cryoEM)
structures
illuminate
origins
activity
on
each
target.
In
mouse
behavioral
studies,
member
series
joint
MOR-antagonist
KOR-inverse-agonist
reversed
morphine-induced
analgesia,
phenocopying
MOR-selective
anti-overdose
agent
naloxone.
Encouragingly,
new
molecule
induced
less
severe
opioid-induced
withdrawal
symptoms
compared
to
naloxone
during
precipitation,
did
not
induce
conditioned-place
aversion,
likely
reflecting
reduction
dysphoria
due
compound’s
KOR-inverse
agonism.
The
strengths
weaknesses
bespoke
docking,
for
opioid
polypharmacology,
will
be
considered.
Addiction Biology,
Journal Year:
2015,
Volume and Issue:
22(2), P. 423 - 434
Published: Dec. 21, 2015
Abstract
Addictions,
including
alcohol
use
disorders,
are
characterized
by
the
loss
of
control
over
drug
seeking
and
consumption,
but
neural
circuits
signaling
mechanisms
responsible
for
transition
from
controlled
to
uncontrolled
abuse
remain
incompletely
understood.
Prior
studies
have
shown
that
‘compulsive‐like’
behaviors
in
rodents,
example,
persistent
responding
ethanol
(EtOH)
despite
punishment,
increased
after
chronic
exposure
EtOH.
The
main
goal
current
study
was
assess
effects
intermittent
EtOH
(CIE)
on
multiple,
putative
measures
compulsive‐like
C57BL/6
J
mice.
Mice
were
exposed
two
or
four
weekly
cycles
CIE
then,
post‐withdrawal,
tested
progressive
ratio
EtOH,
sustained
during
signaled
unavailability
(footshock)
punished
suppression
Results
showed
mice
exhibited
attenuated
as
compared
with
air‐exposed
controls.
By
contrast,
affected
neither
food
reward‐seeking
behavior,
nor
other
seeking.
Ex
vivo
reverse
transcription
polymerase
chain
reaction
analysis
brain
tissue
found
reduced
sensitivity
accompanied
a
significant
increase
gene
expression
GluN1
GluN2A
subunits
N
‐methyl‐
d
‐aspartate
receptor,
specifically
medial
orbitofrontal
cortex.
Moreover,
slice
electrophysiological
revealed
receptor‐mediated
currents
cortex
test‐naïve
Collectively,
findings
add
growing
body
evidence
demonstrating
fosters
resistance
association
adaptations
cortical
glutamatergic
transmission.